Member Info for Themis

Nice RNS, ‘speed is the key to capture market opportunity’, shame those at RMS don’t realise this with their delays.

https://www.londonstockexchange.com/news-article/HAYD/functionalised-graphene-antibacterial-masks/14771343

Haydale getting closer with their partners, competition is hotting up.

https://www.londonstockexchange.com/news-article/HAYD/functionalised-graphene-antibacterial-masks/14771343

I don't think Dr Cave has sold a bean but I would like to see a RNS on the option shares that the directors own to confirm if they have been selling.

Spot on @sharebel

Remember, production IS starting soon, fully expect another RNS updating on this matter. This only affects UK, there could be other production facilities lining up as we speak.

I don't have faith in the current board at all, they let this happen on their watch. I still believe in the product and Gareth Cave, although he has been silenced.

The share price is being pounded now by 250k round sells. Someone is dumping and the board should be making a statement - there can't be many people with that number of shares other than the board?

Until the 100k selling is done this unlikely to go anywhere. I've seen several 100k buys following the sells, perhaps someone is mopping them up too, we need news and we need a holdings RNS to find out what's what.

I know this is good news for the US but I was in Sainsburys recently and hadn't realised, they have a wellness aisle and sell numerous CBD products, so UK deal is surely likley to be considered soon.

Approx 77 million options, but site is not up to date.

https://www.remotemonitoredsystems.com/investor-relations/significant-shareholders/

Shame Paul still has his share options, should be kicked out of the company for his behaviour and timing.

Working with other companies and get this around the world / America’s new president is wanting everyone to wear masks. The vaccine is a long time away yet for everyone.

Government should be knocking on Gareth’s door now, maybe it would save wasting £21million on middle men/consultants.

Very thorough interview, well done.

Great response from Gareth Cave - pity Paul Ryan isn't so open. Paul Ryan caused this mess.

Typical AIM company director, no thought for shareholders and how this looks, just me, me, me.

Another poor interview from Justin, just going through the motions, not asking questions that need to be asked, like ‘Why aren’t the board buying shares?’ Justin is always talking about ‘skin in the game’ too.

Where are the director purchases?

Well done whoever helped to get the article published in main stream press

."....The Company has thereby raised additional funds in excess of £900,000 via recent warrant exercises. As such the Directors do not foresee any current need to raise further funds."

I have contacted RMS recently and got a quick reply to my query, likewise I did the same with Novacyt - nothing and even their investor relations email bounced, ended up using the contact form. AIM companies have some good eggs and alot of bad ones.